Riskpilot← Back to searchSign inGet full accessMEDTECH INNOVATION CLUSTER AS
ASActiveOrg 934145054Nygaardsgata 33A, 1606 FredrikstadBusiness and other management consultancy activities · NACE 7020Est. 2024— employees
Revenue 2025
NOK 189K
+14% vs 2024
EBITDA margin
-28.6%
-169% vs 2024
Equity ratio
82.7%
Financial strength
Net profit 2025
NOK -43K
-169% vs 2024
| Revenue | NOK 189K | +14% |
| EBITDA | NOK -54K | -169% |
| Net profit | NOK -43K | -169% |
| Total assets | NOK 52K | -64% |
| Equity | NOK 43K | -50% |
| Employees | — | — |
Legal name
MEDTECH INNOVATION CLUSTER AS
Org number
934145054
Legal form
Aksjeselskap
NACE code
7020 · Business and other management consultancy activities
Founded
23. september 2024
Share capital
NOK 30 000
Employees
—
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Styrets medlemmer hver for seg. Styrets leder alene.
Company purpose
Selskapet skal drive aktiviteter knyttet til innovasjon, klyngeutvikling og prossestøtte. Formålet er å løse framtidige helseutfordringer gjennom å fremme samarbeid og tillit mellom stat, kommuner, helseforetak, institusjoner, næringsliv og utdannings- og forskningsinstitusjoner. Medtech innovation cluster skal fremme og utvikle prosjektmuligheter og felles bransjesynlighet for deltagende næringsaktører gjennom medlemskap og skal utforme en handlingsplan for disse oppgavene i felleskap med medlemmene. Det velges alltid ett styremedlem fra medlemmene. Medtech innovation cluster as er en ideell virksomhet og et non-profit aksjeselskap. Selskapet har et sosialt formål og betaler ikke ut utbytte til aksjonærene. Overskuddet skal gå inn i virksomheten og blir brukt til å videreutvikle nye og allerede etablerte tilbud i tråd med bedriftens formål.
Address
Nygaardsgata 33A, 1606 Fredrikstad
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2024 | 2025 |
|---|---|---|
| Revenue | 167 | 189 |
| Staff expenses | −0 | −0 |
| EBITDA | 79 | −54 |
| Depreciation & amort. | −0 | −0 |
| EBIT | 79 | −54 |
| Net financials | 0 | −1 |
| Profit before tax | 79 | −54 |
| Tax | 17 | −12 |
| Net profit | 61 | −43 |
| Item | 2024 | 2025 |
|---|---|---|
| Total assets | 145 | 52 |
| Equity | 86 | 43 |
| Long-term debt | 0 | 0 |
| Short-term debt | 60 | 9 |
| Total debt | 60 | 9 |
EBITDA margin
-28.6%
This company
15.8%
Market median
-281% vs market
20242025
Equity ratio
82.7%
This company
38.2%
Market median
+116% vs market
20242025
Return on equity
-98.9%
This company
18.4%
Market median
-638% vs market
20242025
Net profit margin
-22.5%
This company
8.1%
Market median
-378% vs market
20242025
Asset turnover
3.63×
This company
1.12×
Market median
+224% vs market
20242025
Debt / equity
0.21×
This company
0.62×
Market median
+66% vs market
20242025
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (4) | ||
| Board of Directors | 2024 | |
| Board of Directors | 2024 | |
| Board of Directors | 2024 | |
| Chairman | 2024 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of MEDTECH INNOVATION CLUSTER AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Laila Garberg Hagen | Board of Directors | 0 companies |
| Jørgen Schrøder Aanonsen | Board of Directors | 0 companies |
| Nils Sverre Syvertsen | Board of Directors | 0 companies |
| Katrine Schrøder Aanonsen | Chairman | 0 companies |